Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study - Test2 - elhamkhani - TriplyDB

Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study

Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study

http://www.wikidata.org/entity/Q28477435

about

Study of streptomycin-induced ototoxicity: protocol for a longitudinal study.Re-treatment tuberculosis cases categorised as "other": are they properly managed?Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB Mortality in HIV-infected patients with tuberculosis treated with streptomycin and a two-week intensified regimen: data from an HIV cohort study using inverse probability of treatment weighting The challenge of discharging research ethics duties in resource-constrained settings Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon."Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia.Characteristics and treatment outcomes of tuberculosis retreatment cases in three regional hospitals, Uganda.Adding Streptomycin to an Intensified Regimen for Tuberculous Meningitis Improves Survival in HIV-Infected Patients.Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis.The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.Preventing nosocomial MDR TB transmission in sub Saharan Africa: where are we at?Outcomes of HIV-infected patients treated for recurrent tuberculosis with the standard retreatment regimen.Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.Use of drug-susceptibility testing for management of drug-resistant tuberculosis, Thailand, 2004-2008.An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection.Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model.Factors influencing treatment outcomes in tuberculosis patients in Limpopo Province, South Africa, from 2006 to 2010: A retrospective study.Do retreatment tuberculosis patients need special treatment response follow-up beyond the standard regimen? Finding of five-year retrospective study in pastoralist setting.The Bandim tuberculosis score: reliability and comparison with the Karnofsky performance score.A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis Treatment Outcomes of Tuberculosis and Associated Factors in an Ethiopian University Hospital

P2860

Q27318765-B39176A3-A005-4F55-A79E-92F4CB3F8F52 Q28478395-B4C09CBE-251E-4E14-B6AB-803275BA95A4 Q28480467-0B5FFB50-BB43-4A79-9097-F0A149968650 Q28536869-43B2E39F-8EDD-4291-97B1-F15D0259A3B5 Q28550707-EC387AAE-F65A-470A-BB87-C5D19123CFFB Q31102969-37808A59-3CE2-4AA8-AE28-CB6B5403BD2B Q33851296-0C228679-8DF4-4C01-89E3-16428A59C81C Q34205098-81908BCE-8C58-45B8-AC39-B283FFEF6C8C Q35100096-CFEC77EC-35A5-446C-857D-E998E0BA83EA Q35114820-493CBEFD-796C-4839-9738-8590D5616035 Q35207150-5C993FE4-F4DB-4865-A195-3E37E2CC3554 Q35621974-5C600A15-D778-4125-A5D7-E85CAB8E4254 Q35681236-99CE7F8E-83AC-4366-A855-2DE5A3E9253A Q35719180-0DE07F1A-B268-416D-ADC0-25FB30BE6D85 Q35963971-C82C5C16-CF0B-472D-BB9E-51BB1EF5FE34 Q36238223-49FE3823-C9FA-43A1-A9EC-57E5F2C4133F Q36454787-7EEE8A58-93CA-4584-8C65-C7E4997B9128 Q36647864-4CD441E0-ED47-422A-B605-E2983F7F28C1 Q36913967-3B5BE7D9-E136-488F-B185-42FBC13B4385 Q37423406-53CF9901-3F00-4265-A801-58A32F158EE0 Q37621698-0FD78629-0A2F-44E4-A704-A56DC4D644EA Q38028326-8E585C27-B807-4A44-AF5D-AC2555D4E28F Q38842946-40E11A13-DD56-4A8B-B11B-837EBDC0B19A Q39149785-DAB3FDB3-5FA1-4DBE-B4B8-2213C96F0EBF Q46386436-87E9A96B-EAF1-4FB8-88AC-7B7DA1B5915A Q53108706-0C7B8829-E3C1-445B-BFBA-9292AE7E342F Q58794430-B59E11CA-BA1E-4F61-9EDC-EABDEF95ADB7 Q59122909-F5672A64-24B8-42DC-89DA-4936E10325DD

P2860

Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study

http://www.wikidata.org/entity/Q28477435

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effectiveness of the standard ...... da: a prospective cohort study

@ast

Effectiveness of the standard ...... da: a prospective cohort study

@en

Effectiveness of the standard ...... da: a prospective cohort study

@nl

type

label

Effectiveness of the standard ...... da: a prospective cohort study

@ast

Effectiveness of the standard ...... da: a prospective cohort study

@en

Effectiveness of the standard ...... da: a prospective cohort study

@nl

prefLabel

Effectiveness of the standard ...... da: a prospective cohort study

@ast

Effectiveness of the standard ...... da: a prospective cohort study

@en

Effectiveness of the standard ...... da: a prospective cohort study

@nl

P1433

Q28477435-3568E466-811B-428B-9012-A68C062DCF8B

P1476

Q28477435-EA68A253-C8A3-46BB-8783-B18A17D05653

P2093

Q28477435-0CEEF184-F2A6-4541-877C-60087B3A3527

Q28477435-121A559B-E665-4000-B743-9708887EA2B9

Q28477435-2E4DB8AF-45ED-4C6A-8D47-578F4CAA56CF

Q28477435-3B94C074-22B9-4408-90FA-595027F601D5

Q28477435-526E59FC-5D8D-45C3-B87F-87DD5CCC6355

Q28477435-6BB86B84-45DB-42CD-9F60-12B47F79126F

Q28477435-8E74A256-490C-4FBD-A348-EF1E20207086

Q28477435-95ED5704-95D6-4457-887E-D0820EDF5621

Q28477435-9BBB19A4-CFD9-4FF2-829F-86E5876D21E6

Q28477435-C61B7853-5333-488F-92B2-BB7D9112528C

P2860

Q28477435-31CC9272-9999-4054-92D4-9ADE1B8BFD5C

Q28477435-38DF78EB-0A5C-468A-A6FE-4AAB26A7F0D8

Q28477435-3FCE656E-1E46-4EFC-B31E-7E2D8E0C673F

Q28477435-3FF6B60C-A40E-4AD2-9CB6-156BA117700C

Q28477435-42DFC42C-2BDD-4CDF-8291-F0BF95635635

Q28477435-4801ED4E-53B3-4996-968B-BD32F9DFF54D

Q28477435-49BA6A90-9A65-4904-A2F4-DB521946338D

Q28477435-53119A6C-6F98-45D4-B196-DF6DC715C9CF

Q28477435-53169B3E-19A0-4F6E-B168-9FBE8AE8A047

Q28477435-5E06D94D-7B9A-46A8-86DE-49742052EAD7

P304

Q28477435-6A4738E5-50B2-45A4-9EE1-4815544CF7D5

P31

Q28477435-68DE7891-B5F5-4417-A9CA-0BADE14E0DFD

P3181

Q28477435-AB87BC25-982A-4D7B-B25A-6881604D1724

P356

Q28477435-D562D81B-415B-4165-9692-0ACF7E494946

P407

Q28477435-7B5E8000-8E3D-4C8A-95C4-03A63903010E

P433

Q28477435-7635F1E9-DDCD-4500-8E51-078470474F45

P478

Q28477435-DAE14D0D-159A-4107-A61B-E2D3208F686D

P50

Q28477435-1611FCA4-0C59-471F-BFDF-743CB94207DE

Q28477435-32BB6FA1-67AC-42E4-AFFA-2F32AC35181E

Q28477435-574A71B8-AD01-42F5-AA18-C2615FC62C3F

Q28477435-D946B2D4-AF14-447E-B4AD-298ACE1CF4B5

Q28477435-FC45F28B-D460-480B-AAFA-79FE257E8430

P577

Q28477435-07E60783-12E9-4AB7-8679-0FA7A0B4A05A

P5875

Q28477435-AFED3D40-1839-4858-940A-1A3F74E4824B

P698

Q28477435-336C2EB9-E570-4485-A0BE-A7ECBAC29A60

P921

Q28477435-256993DD-307F-40D1-98C5-C9BF2CFB23AA

Q28477435-514E1C95-945C-4C60-A6B3-25325E3EC281

Q28477435-78F3F697-69A0-4FD9-8C5D-F2567BE1F670

P932

Q28477435-95658B8C-A665-4BB0-AB9E-5AFD9D84E17E

P3181

P356

JOURNAL.PMED.1000427

P1433

P1476

Effectiveness of the standard ...... da: a prospective cohort study

@en

P2093

Alphonse Okwera

http://www.w3.org/2001/XMLSchema#string

Beth Temple

http://www.w3.org/2001/XMLSchema#string

Edward C Jones-López

http://www.w3.org/2001/XMLSchema#string

Francis Mumbowa

http://www.w3.org/2001/XMLSchema#string

Grace Nyakoojo

http://www.w3.org/2001/XMLSchema#string

Irene Ayakaka

http://www.w3.org/2001/XMLSchema#string

Jonathan Levin

http://www.w3.org/2001/XMLSchema#string

Kathleen D Eisenach

http://www.w3.org/2001/XMLSchema#string

Kevin Fennelly

http://www.w3.org/2001/XMLSchema#string

Nancy Reilly

http://www.w3.org/2001/XMLSchema#string

P2860

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This st

Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance

Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis

Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis

Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda

Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.

Recent tuberculosis advances in Latin America

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

P304

e1000427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

707078

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1000427

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alison M Elliott

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50597098

http://www.w3.org/2001/XMLSchema#string

P698

21423586

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

Alþjóðaheilbrigðismálastofnunin

P932

3058098

http://www.w3.org/2001/XMLSchema#string